Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| ciliated cell | 9 studies | 25% ± 8% | |
| epithelial cell | 5 studies | 24% ± 9% | |
| endothelial cell | 5 studies | 20% ± 4% | |
| macrophage | 3 studies | 27% ± 10% | |
| astrocyte | 3 studies | 30% ± 5% | |
| GABAergic neuron | 3 studies | 38% ± 2% | |
| glutamatergic neuron | 3 studies | 40% ± 2% | |
| interneuron | 3 studies | 34% ± 17% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 4 studies | 27% ± 9% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| thymus | 100% | 439.84 | 652 / 653 | 100% | 11.46 | 604 / 605 |
| liver | 100% | 1039.79 | 226 / 226 | 100% | 16.87 | 404 / 406 |
| adrenal gland | 100% | 2091.64 | 258 / 258 | 99% | 14.16 | 227 / 230 |
| kidney | 100% | 1273.91 | 89 / 89 | 99% | 19.31 | 889 / 901 |
| ovary | 100% | 798.48 | 180 / 180 | 98% | 7.85 | 423 / 430 |
| breast | 99% | 292.15 | 456 / 459 | 97% | 8.26 | 1087 / 1118 |
| pancreas | 98% | 167.30 | 321 / 328 | 96% | 4.64 | 170 / 178 |
| prostate | 98% | 271.47 | 239 / 245 | 95% | 5.13 | 478 / 502 |
| brain | 99% | 288.50 | 2611 / 2642 | 91% | 3.56 | 645 / 705 |
| intestine | 99% | 356.89 | 953 / 966 | 90% | 3.96 | 476 / 527 |
| lung | 98% | 303.16 | 569 / 578 | 90% | 5.11 | 1045 / 1155 |
| bladder | 100% | 191.14 | 21 / 21 | 87% | 4.01 | 440 / 504 |
| uterus | 98% | 262.95 | 167 / 170 | 88% | 4.50 | 403 / 459 |
| stomach | 87% | 144.08 | 313 / 359 | 91% | 4.17 | 260 / 286 |
| esophagus | 95% | 183.44 | 1375 / 1445 | 78% | 3.05 | 142 / 183 |
| skin | 90% | 141.95 | 1627 / 1809 | 54% | 2.20 | 253 / 472 |
| muscle | 99% | 296.54 | 798 / 803 | 0% | 0 | 0 / 0 |
| adipose | 99% | 395.16 | 1193 / 1204 | 0% | 0 | 0 / 0 |
| spleen | 98% | 187.57 | 236 / 241 | 0% | 0 | 0 / 0 |
| blood vessel | 96% | 297.99 | 1285 / 1335 | 0% | 0 | 0 / 0 |
| heart | 95% | 291.95 | 814 / 861 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 86% | 4.14 | 69 / 80 |
| tonsil | 0% | 0 | 0 / 0 | 69% | 2.46 | 31 / 45 |
| peripheral blood | 67% | 120.06 | 621 / 929 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 59% | 2.27 | 17 / 29 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0019303 | Biological process | D-ribose catabolic process |
| GO_0046835 | Biological process | carbohydrate phosphorylation |
| GO_0006098 | Biological process | pentose-phosphate shunt |
| GO_0005829 | Cellular component | cytosol |
| GO_0005634 | Cellular component | nucleus |
| GO_0042802 | Molecular function | identical protein binding |
| GO_0005515 | Molecular function | protein binding |
| GO_0046872 | Molecular function | metal ion binding |
| GO_0005524 | Molecular function | ATP binding |
| GO_0004747 | Molecular function | ribokinase activity |
| Gene name | RBKS |
| Protein name | Ribokinase (RK) (EC 2.7.1.15) Ribokinase |
| Synonyms | RBSK |
| Description | FUNCTION: Catalyzes the phosphorylation of ribose at O-5 in a reaction requiring ATP and magnesium. The resulting D-ribose-5-phosphate can then be used either for sythesis of nucleotides, histidine, and tryptophan, or as a component of the pentose phosphate pathway. . |
| Accessions | H7C091 ENST00000302188.8 [Q9H477-1] E9PBU0 ENST00000453412.1 E7EQ18 Q9H477 ENST00000458185.1 ENST00000449378.1 |
